#pfizer

[ follow ]
#pharmaceuticals
fromFortune
6 months ago
Business

Pfizer stock surges after activist takes $1 billion stake

Pfizer's stock peaked during the pandemic but has faced significant losses as demand for COVID-19 products faltered.
fromBusiness Insider
16 hours ago
European startups

Pfizer's CEO said the company could make 'tremendous investments' in the US if Trump's tariffs go away

Tariff uncertainty is limiting Pfizer's investment potential in R&D and manufacturing in the US.
from24/7 Wall St.
1 week ago
NYC startup

Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (April 2025)

Pfizer's stock has declined significantly despite strong earnings and a high dividend yield.
The company anticipates revenue growth driven by new drug sales, especially in oncology.
from24/7 Wall St.
5 months ago
Miscellaneous

Opinion: Pfizer (PFE) Stock Will Hit $22 Before It Hits $33 During Trump's Presidency

Trump's election win led to initial market growth, though pharmaceuticals may be adversely affected.
fromFortune
6 months ago
Business

Pfizer stock surges after activist takes $1 billion stake

Pfizer's stock peaked during the pandemic but has faced significant losses as demand for COVID-19 products faltered.
fromBusiness Insider
16 hours ago
European startups

Pfizer's CEO said the company could make 'tremendous investments' in the US if Trump's tariffs go away

Tariff uncertainty is limiting Pfizer's investment potential in R&D and manufacturing in the US.
from24/7 Wall St.
1 week ago
NYC startup

Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (April 2025)

Pfizer's stock has declined significantly despite strong earnings and a high dividend yield.
The company anticipates revenue growth driven by new drug sales, especially in oncology.
from24/7 Wall St.
5 months ago
Miscellaneous

Opinion: Pfizer (PFE) Stock Will Hit $22 Before It Hits $33 During Trump's Presidency

Trump's election win led to initial market growth, though pharmaceuticals may be adversely affected.
more#pharmaceuticals
#stock-market
fromBusiness Insider
6 months ago
Miscellaneous

Activist investor Starboard has just informed Pfizer it has taken a significant stake

Starboard Value has taken a significant stake in Pfizer amidst falling stock prices since the COVID-19 vaccine rollout.
from24/7 Wall St.
8 months ago
Business

3 Stocks Under $50 Smart Investors Should Buy Hand Over Fist

Start investing early, regardless of cash amount, to benefit from long-term stock growth.
from24/7 Wall St.
1 week ago
Startup companies

3 High Yielding Dividend Stocks Near 52-Week Lows

Market uncertainty presents opportunities for strategic investments in resilient stocks.
Dividend investors can capitalize on low prices of high-yield stocks during downturns.
fromBusiness Insider
6 months ago
Miscellaneous

Activist investor Starboard has just informed Pfizer it has taken a significant stake

Starboard Value has taken a significant stake in Pfizer amidst falling stock prices since the COVID-19 vaccine rollout.
from24/7 Wall St.
8 months ago
Business

3 Stocks Under $50 Smart Investors Should Buy Hand Over Fist

Start investing early, regardless of cash amount, to benefit from long-term stock growth.
from24/7 Wall St.
1 week ago
Startup companies

3 High Yielding Dividend Stocks Near 52-Week Lows

Market uncertainty presents opportunities for strategic investments in resilient stocks.
Dividend investors can capitalize on low prices of high-yield stocks during downturns.
more#stock-market
#clinical-trials
Wearables
fromtime.com
2 weeks ago

Pfizer Ends Development of Its Obesity Pill

Pfizer has halted the development of danuglipron due to safety concerns, but remains committed to exploring other obesity treatment options.
fromwww.mercurynews.com
7 months ago
OMG science

Pfizer drug helped cancer patients regain weight, study shows

Pfizer's ponsegromab shows potential in helping cancer patients regain weight lost due to cachexia.
fromABC7 San Francisco
9 months ago
Medicine

Pfizer targets obesity with new once-daily Danuglipron drug

Pfizer has selected the preferred once-daily modified release formulation of the obesity drug danuglipron, a significant milestone in its development.
Wearables
fromtime.com
2 weeks ago

Pfizer Ends Development of Its Obesity Pill

Pfizer has halted the development of danuglipron due to safety concerns, but remains committed to exploring other obesity treatment options.
fromwww.mercurynews.com
7 months ago
OMG science

Pfizer drug helped cancer patients regain weight, study shows

Pfizer's ponsegromab shows potential in helping cancer patients regain weight lost due to cachexia.
fromABC7 San Francisco
9 months ago
Medicine

Pfizer targets obesity with new once-daily Danuglipron drug

Pfizer has selected the preferred once-daily modified release formulation of the obesity drug danuglipron, a significant milestone in its development.
more#clinical-trials
#biontech
fromIPWatchdog.com | Patents & Intellectual Property Law
1 year ago
Coronavirus

GSK Says Pfizer Infringed Five Patents Relating to Comirnaty COVID Vaccine

GlaxoSmithKline (GSK) filed a complaint alleging Pfizer and BioNTech's COVID-19 vaccines used GSK's patented inventions, highlighting unacknowledged revolutionary platform application.
fromIPWatchdog.com | Patents & Intellectual Property Law
1 year ago
Coronavirus

GSK Says Pfizer Infringed Five Patents Relating to Comirnaty COVID Vaccine

GlaxoSmithKline (GSK) filed a complaint alleging Pfizer and BioNTech's COVID-19 vaccines used GSK's patented inventions, highlighting unacknowledged revolutionary platform application.
more#biontech
#healthcare
US Elections
fromBusiness Insider
1 month ago

Pfizer's CEO says he's got a plan to deal with Trump's tariffs - move overseas drug manufacturing to the US

Pfizer may relocate drug manufacturing back to the US in response to Trump's tariffs.
fromBusiness Insider
2 months ago
Public health

Pfizer's CEO says he's had dinner with Trump's health secretary pick, RFK Jr.

Bourla expresses optimism regarding RFK Jr.'s potential role as health secretary and their shared interests in health issues.
US Elections
fromBusiness Insider
1 month ago

Pfizer's CEO says he's got a plan to deal with Trump's tariffs - move overseas drug manufacturing to the US

Pfizer may relocate drug manufacturing back to the US in response to Trump's tariffs.
fromBusiness Insider
2 months ago
Public health

Pfizer's CEO says he's had dinner with Trump's health secretary pick, RFK Jr.

Bourla expresses optimism regarding RFK Jr.'s potential role as health secretary and their shared interests in health issues.
more#healthcare
#covid-19
Alternative medicine
fromNatural Health News
2 months ago

Pfizer Vaccine Scandal: Shocking Revelations You Need to Know

Concerns about corporate influence and transparency in Pfizer's vaccine distribution amid the COVID-19 pandemic have emerged, highlighted by troubling studies and criticism.
Coronavirus
fromTruthout
8 months ago

Summer COVID Wave Prompts Early Emergency Approval of New Vaccines

The FDA has approved updated vaccines from Pfizer and Moderna to combat the KP.2 COVID-19 strain amid severe summer infections.
fromwww.theguardian.com
2 months ago
Europe politics

I asked to see Ursula von der Leyen's texts to Pfizer's boss and she went to court to stop me. Why the secrecy? | Alexander Fanta

Ursula von der Leyen's negotiations with Pfizer were crucial in securing vaccine doses during the pandemic.
Alternative medicine
fromNatural Health News
2 months ago

Pfizer Vaccine Scandal: Shocking Revelations You Need to Know

Concerns about corporate influence and transparency in Pfizer's vaccine distribution amid the COVID-19 pandemic have emerged, highlighted by troubling studies and criticism.
Coronavirus
fromTruthout
8 months ago

Summer COVID Wave Prompts Early Emergency Approval of New Vaccines

The FDA has approved updated vaccines from Pfizer and Moderna to combat the KP.2 COVID-19 strain amid severe summer infections.
fromwww.theguardian.com
2 months ago
Europe politics

I asked to see Ursula von der Leyen's texts to Pfizer's boss and she went to court to stop me. Why the secrecy? | Alexander Fanta

Ursula von der Leyen's negotiations with Pfizer were crucial in securing vaccine doses during the pandemic.
more#covid-19
fromBusiness Insider
6 months ago
Miscellaneous

Activist hedge fund Starboard met with Pfizer last week. Here's what went down.

Starboard is advocating for increased accountability and improvements in Pfizer's operational and financial strategies. Smith highlights a poor return on investments.
fromFortune
6 months ago
Miscellaneous

Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis

Activist investor Starboard Value's proxy fight against Pfizer has intensified, with claims of CEO Bourla's underperformance amid shifting loyalties from former Pfizer executives.
fromIrish Independent
6 months ago
Business

Pfizer set to axe 200 jobs in Ireland

Pfizer is expected to cut up to 200 jobs in Ireland as part of a global cost-reduction initiative.
#mural
fromABC News
7 months ago
NYC real estate

A mural honoring scientists hung in Pfizer's NYC lobby for 60 years. Now it's up for grabs

The future of a historic mural at Pfizer's former headquarters hangs in the balance as conservationists seek a new location before its imminent demolition.
fromSFGATE
7 months ago
NYC real estate

A mural honoring scientists hung in Pfizer's NYC lobby for 60 years. Now it's up for grabs

The mural "Medical Research Through the Ages" faces potential destruction as Pfizer's headquarters is converted, prompting urgent efforts to find it a new home.
fromBrooklyn Eagle
7 months ago
NYC real estate

Mural honoring scientists in Pfizer's NYC lobby is now up for grabs

The 'Medical Research Through the Ages' mural may be lost if a new home isn't found soon.
fromABC News
7 months ago
NYC real estate

A mural honoring scientists hung in Pfizer's NYC lobby for 60 years. Now it's up for grabs

The future of a historic mural at Pfizer's former headquarters hangs in the balance as conservationists seek a new location before its imminent demolition.
fromSFGATE
7 months ago
NYC real estate

A mural honoring scientists hung in Pfizer's NYC lobby for 60 years. Now it's up for grabs

The mural "Medical Research Through the Ages" faces potential destruction as Pfizer's headquarters is converted, prompting urgent efforts to find it a new home.
fromBrooklyn Eagle
7 months ago
NYC real estate

Mural honoring scientists in Pfizer's NYC lobby is now up for grabs

The 'Medical Research Through the Ages' mural may be lost if a new home isn't found soon.
more#mural
#art-conservation
fromThe Seattle Times
7 months ago
NYC real estate

A mural honoring scientists hung in Pfizer's NYC lobby for 60 years. Now it's up for grabs

Urgent efforts are underway to save Pfizer's historic "Medical Research Through the Ages" mural from demolition as the building is converted into residential apartments.
fromNBC New York
7 months ago
NYC real estate

A mural honoring scientists hung in Pfizer's NYC lobby for 60 years. Now it's up for grabs

The iconic mural at Pfizer's NYC headquarters faces possible destruction due to building renovations, as conservationists scramble to relocate it.
fromThe Seattle Times
7 months ago
NYC real estate

A mural honoring scientists hung in Pfizer's NYC lobby for 60 years. Now it's up for grabs

Urgent efforts are underway to save Pfizer's historic "Medical Research Through the Ages" mural from demolition as the building is converted into residential apartments.
fromNBC New York
7 months ago
NYC real estate

A mural honoring scientists hung in Pfizer's NYC lobby for 60 years. Now it's up for grabs

The iconic mural at Pfizer's NYC headquarters faces possible destruction due to building renovations, as conservationists scramble to relocate it.
more#art-conservation
Alternative medicine
fromGreenmedinfo
9 months ago

The Tables Turn: Pfizer Accused of Misinformation in Landmark Kansas Lawsuit

Pharmaceutical giant Pfizer faces accusations of spreading misinformation about its COVID-19 vaccine, highlighting concerns over transparency and deceptive practices.
[ Load more ]